IL-1ra Dose-range Study for Moderate-to-severe TBI Patients

NCT02997371 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Traumatic Brain INjury

Interventions

DRUG: Anakinra Prefilled Syringe
DRUG: Isotonic saline

Sponsor

Adel Helmy

Collaborators

[object Object]